All Stories

  1. Automation to reduce human effort in the document selection stage of systematic evidence syntheses: protocol for a systematic review of current approaches.
  2. Automation to reduce human effort in the document selection stage of systematic evidence syntheses: protocol for a systematic review of current approaches.
  3. Evaluation of Elicit, SciSpace and Nested Knowledge in replicating three systematic reviews
  4. The GALENOS approach to triangulating evidence: a structured approach for integrating information from human and animal studies
  5. The effect of heat exposure on mood disorders and psychosis: Protocol for a living systematic review of human and non-human studies (Preprint)
  6. Pro-dopaminergic pharmacological interventions for anhedonia in depression: a living systematic review and network meta-analysis of human and animal studies
  7. Developing treatments for cerebral small vessel disease: a scoping review of licensed interventions for potential repurposing
  8. A How-to Guide for Research Improvement within Research-Performing Institutions
  9. Mechanisms through which exercise reduces symptom severity and/or functional impairment in posttraumatic stress disorder (PTSD): Protocol for a living systematic review of human and non-human studies
  10. Building a synthesis-ready research ecosystem: fostering collaboration and open science to accelerate biomedical translation
  11. The therapeutic potential of exercise in post-traumatic stress disorder and its underlying mechanisms: A living systematic review of human and non-human studies
  12. Mechanisms through which exercise reduces symptom severity and/or functional impairment in posttraumatic stress disorder (PTSD): Protocol for a living systematic review of human and non-human studies
  13. Muscarinic receptor agonists and positive allosteric modulators in animal models of psychosis: protocol for a systematic review and meta-analysis
  14. Testing the usefulness of a quality system in preclinical research
  15. Triangulating evidence from the GALENOS living systematic review on trace amine-associated receptor 1 (TAAR1) agonists in psychosis
  16. Developing treatments for cerebral small vessel disease: a scoping review of licensed interventions for potential repurposing
  17. Safety and efficacy of memantine and trazodone versus placebo for motor neuron disease (MND SMART): stage two interim analysis from the first cycle of a phase 3, multiarm, multistage, randomised, adaptive platform trial
  18. A Systematic Online Living Evidence Summary of experimental Alzheimer’s disease research
  19. Strategy for developing data standards in support of automation of Systematic Reviews
  20. Analysis of animal-to-human translation shows that only 5% of animal-tested therapeutic interventions obtain regulatory approval for human applications
  21. Trace amine-associated receptor 1 (TAAR1) agonism for psychosis: a living systematic review and meta-analysis of human and non-human data
  22. Understanding the provenance and quality of methods is essential for responsible reuse of FAIR data
  23. Genetically modified animals as models of neurodevelopmental conditions: A review of systematic review reporting quality
  24. Prevention of infections and fever to improve outcome in older patients with acute stroke (PRECIOUS): a randomised, open, phase III, multifactorial, clinical trial with blinded outcome assessment
  25. Evaluating artificial intelligence software for delineating hemorrhage extent on CT brain imaging in stroke
  26. Genetically-modified animals as models of neurodevelopmental conditions: a review of systematic review reporting quality
  27. Mechanisms through which exercise reduces symptom severity and/or functional impairment in posttraumatic stress disorder (PTSD): Protocol for a living systematic review of human and non-human studies
  28. Pro-dopaminergic pharmacological interventions for anhedonia in depression: protocol for a living systematic review of human and non-human studies
  29. From data deluge to publomics: How AI can transform animal research
  30. Blood biomarker changes following therapeutic hypothermia in ischemic stroke
  31. A Systematic Online Living Evidence Summary of experimental Alzheimer’s disease research
  32. The Automated Systematic Search Deduplicator (ASySD): a rapid, open-source, interoperable tool to remove duplicate citations in biomedical systematic reviews
  33. The UK Reproducibility Network: A progress report
  34. Trace amine-associated receptor 1 (TAAR1) agonists for psychosis: protocol for a living systematic review and meta-analysis of human and non-human studies.
  35. New living evidence resource of human and non-human studies for early intervention and research prioritisation in anxiety, depression and psychosis
  36. Identifying a research agenda for postgraduate taught education in the UK: lessons from a machine learning facilitated systematic scoping review
  37. Accuracy of artificial intelligence software for CT angiography in stroke
  38. Systematic online living evidence summaries: emerging tools to accelerate evidence synthesis
  39. Designing, conducting, and reporting reproducible animal experiments
  40. Advanced methods and implementations for the meta-analyses of animal models: Current practices and future recommendations
  41. Screening for in vitro systematic reviews: a comparison of screening methods and training of a machine learning classifier
  42. EFFECTS OF GALACTO-OLIGOSACCHARIDE PREBIOTICS IN THE FLINDERS SENSITIVE LINE RAT MODEL OF DEPRESSION ON BEHAVIOURAL OUTCOMES
  43. Frequency and Phenotype Associations of Rare Variants in 5 Monogenic Cerebral Small Vessel Disease Genes in 200,000 UK Biobank Participants
  44. PICO entity extraction for preclinical animal literature
  45. The EQIPD framework for rigor in the design, conduct, analysis and documentation of animal experiments
  46. Screening for in vitro systematic reviews: a comparison of screening methods and training of a machine learning classifier
  47. Systematic Online Living Evidence Summaries: emerging tools to accelerate evidence synthesis
  48. Motor Neuron Disease Systematic Multi-Arm Adaptive Randomised Trial (MND-SMART): a multi-arm, multi-stage, adaptive, platform, phase III randomised, double-blind, placebo-controlled trial of repurposed drugs in motor neuron disease
  49. Meta-analysis on reporting practices as a source of heterogeneity in in vitro cancer research
  50. Effectiveness of biomaterial-based combination strategies for spinal cord repair – a systematic review and meta-analysis of preclinical literature
  51. Improving the reproducibility and integrity of research: what can different stakeholders contribute?
  52. A Systematic Approach to Identify Neuroprotective Interventions for Motor Neuron Disease
  53. MDAR (Material, Design, Analysis Reporting): A Modular Framework for Transparent Reporting in the Life Sciences
  54. What has preclinical systematic review ever done for us?
  55. The reproducibility debate is an opportunity, not a crisis
  56. Improving research quality: the view from the UK Reproducibility Network institutional leads for research improvement
  57. From grassroots to global: A blueprint for building a reproducibility network
  58. Risk of bias assessment in preclinical literature using natural language processing
  59. Using median survival in meta-analysis of experimental time-to-event data
  60. PICO Entity Extraction For Preclinical Animal Literature
  61. Meta-analysis on reporting practices as a source of heterogeneity in in vitro cancer research
  62. Technological advances in preclinical meta-research
  63. Building a Systematic Online Living Evidence Summary of COVID-19 Research
  64. Red blood cell transfusion in animal models of acute brain injuries: a systematic review protocol
  65. Risk of Bias Assessment in Preclinical Literature using Natural Language Processing
  66. Introduction to the EQIPD quality system
  67. Meta-analysis of variation suggests that embracing variability improves both replicability and generalizability in preclinical research
  68. Epidemiology and reporting characteristics of preclinical systematic reviews
  69. The Automated Systematic Search Deduplicator (ASySD): a rapid, open-source, interoperable tool to remove duplicate citations in biomedical systematic reviews
  70. The MDAR (Materials Design Analysis Reporting) Framework for transparent reporting in the life sciences
  71. Regulatory delays in a multinational clinical stroke trial
  72. Systematic review and meta-analysis of cannabinoids, cannabis-based medicines, and endocannabinoid system modulators tested for antinociceptive effects in animal models of injury-related or pathological persistent pain
  73. Development and uptake of an online systematic review platform: the early years of the CAMARADES Systematic Review Facility (SyRF)
  74. Results of a randomised controlled trial comparing two different incentives to improve survey response rates
  75. Using Median Survival in Meta-analysis of Experimental Time-to-event Data
  76. Protocol for an analysis of in vivo reporting standards by journal, institution and funder
  77. Comparison of commonly used methods in random effects meta-analysis: application to preclinical data in drug discovery research
  78. Can harmonisation of outcomes bridge the translation gap for pre-clinical research? A systematic review of outcomes measured in mouse models of type 2 diabetes
  79. Intravenous alteplase for stroke with unknown time of onset guided by advanced imaging: systematic review and meta-analysis of individual patient data
  80. Feasibility of reporting results of large randomised controlled trials to participants: experience from the Fluoxetine Or Control Under Supervision (FOCUS) trial
  81. Effects of dietary fat manipulation on cognition in mice and rats: protocol for a systematic review and meta-analysisEffects of dietary fat manipulation on cognition in mice and rats: protocol for a systematic review and meta-analysis
  82. Red Blood Cell Transfusion in Animal Models of Acute Brain Injuries: A Systematic Review Protocol
  83. Embrace heterogeneity to improve reproducibility: A perspective from meta-analysis of variation in preclinical research
  84. The worldwide clinical trial research response to the COVID-19 pandemic - the first 100 days
  85. Identifying and understanding factors that affect the translation of therapies from the laboratory to patients: a study protocol
  86. The worldwide clinical trial research response to the COVID-19 pandemic - the first 100 days
  87. A Systematic Review and Meta-Analysis of Hypothermia in Experimental Traumatic Brain Injury: Why Have Promising Animal Studies Not Been Replicated in Pragmatic Clinical Trials?
  88. Neurological and neuropsychiatric complications of COVID-19 in 153 patients: a UK-wide surveillance study
  89. The ARRIVE guidelines 2.0: Updated guidelines for reporting animal research
  90. Reporting animal research: Explanation and elaboration for the ARRIVE guidelines 2.0
  91. The ARRIVE guidelines 2.0: Updated guidelines for reporting animal research
  92. The ARRIVE guidelines 2.0: Updated guidelines for reporting animal research*
  93. The ARRIVE guidelines 2.0: Updated guidelines for reporting animal research
  94. The ARRIVE guidelines 2.0: Updated guidelines for reporting animal research
  95. The ARRIVE guidelines 2.0: updated guidelines for reporting animal research
  96. Identifying and understanding factors that affect the translation of therapies from the laboratory to patients: a study protocol
  97. Real-world Independent Testing of e-ASPECTS Software (RITeS): statistical analysis plan
  98. Systematic review of guidelines for internal validity in the design, conduct and analysis of preclinical biomedical experiments involving laboratory animals
  99. FAIR SCI Ahead: The Evolution of the Open Data Commons for Pre-Clinical Spinal Cord Injury Research
  100. UK consensus on pre-clinical vascular cognitive impairment functional outcomes assessment: Questionnaire and workshop proceedings
  101. Introducing our series: research synthesis and meta-research in biology
  102. Framework for advancing rigorous research
  103. Meta-analysis of targeted temperature management in animal models of cardiac arrest
  104. Research Culture and Reproducibility
  105. Ischaemic stroke
  106. Compressive Pressure Versus Time in Cauda Equina Syndrome
  107. The ARRIVE guidelines 2019: updated guidelines for reporting animal research
  108. Reporting animal research: Explanation and Elaboration for the ARRIVE guidelines 2019
  109. Effects of antiplatelet therapy on stroke risk by brain imaging features of intracerebral haemorrhage and cerebral small vessel diseases: subgroup analyses of the RESTART randomised, open-label trial
  110. Extending thrombolysis to 4·5–9 h and wake-up stroke using perfusion imaging: a systematic review and meta-analysis of individual patient data
  111. A randomised controlled trial of an Intervention to Improve Compliance with the ARRIVE guidelines (IICARus)
  112. Outcome heterogeneity and bias in acute experimental spinal cord injury
  113. Effects of antiplatelet therapy after stroke due to intracerebral haemorrhage (RESTART): a randomised, open-label trial
  114. Animal models of chemotherapy-induced peripheral neuropathy: A machine-assisted systematic review and meta-analysis
  115. Thrombolysis Guided by Perfusion Imaging up to 9 Hours after Onset of Stroke
  116. Administration of galacto-oligosaccharide prebiotics in the Flinders Sensitive Line animal model of depression
  117. Protocol for a systematic review and meta-analysis of data from preclinical studies employing forced swimming test: an update
  118. Towards minimum reporting standards for life scientists
  119. Therapeutic hypothermia for acute ischaemic stroke. Results of a European multicentre, randomised, phase III clinical trial
  120. A European initiative to unclog pipeline for new medicines
  121. The development and evaluation of an online application to assist in the extraction of data from graphs for use in systematic reviews
  122. Reader response: Evaluating depression and suicidality in tetrabenazine users with Huntington disease
  123. Did a change in Nature journals’ editorial policy for life sciences research improve reporting?
  124. Warlow's Stroke
  125. The development and evaluation of an online application to assist in the extraction of data from graphs for use in systematic reviews
  126. Machine learning algorithms for systematic review: reducing workload in a preclinical review of animal studies and reducing human screening error
  127. Identifying stroke therapeutics from preclinical models: A protocol for a novel application of network meta-analysis
  128. Effects of fluoxetine on functional outcomes after acute stroke (FOCUS): a pragmatic, double-blind, randomised, controlled trial
  129. Design of Meta-Analysis Studies
  130. Targeting mitochondrial dysfunction in amyotrophic lateral sclerosis: a systematic review and meta-analysis
  131. Reproducibility and Rigor in Animal-Based Research
  132. The development and evaluation of an online application to assist in the extraction of data from graphs for use in systematic reviews
  133. Potentially serious incidental findings on brain and body magnetic resonance imaging of apparently asymptomatic adults: systematic review and meta-analysis
  134. Protocol for a systematic review of guidelines for rigour in the design, conduct and analysis of biomedical experiments involving laboratory animals
  135. The reproducibility opportunity
  136. NXY-059, a Failed Stroke Neuroprotectant, Offers No Protection to Stem Cell-Derived Human Neurons
  137. A randomised controlled trial of an Intervention to Improve Compliance with the ARRIVE guidelines (IICARus)
  138. PRECIOUS: PREvention of Complications to Improve OUtcome in elderly patients with acute Stroke. Rationale and design of a randomised, open, phase III, clinical trial with blinded outcome assessment
  139. Small vessels, dementia and chronic diseases – molecular mechanisms and pathophysiology
  140. Effect size and statistical power in the rodent fear conditioning literature – A systematic review
  141. Animal models of chemotherapy-induced peripheral neuropathy: a machine-assisted systematic review and meta-analysis A comprehensive summary of the field to inform robust experimental design
  142. Automation of citation screening in pre-clinical systematic reviews
  143. The REstart or STop Antithrombotics Randomised Trial (RESTART) after stroke due to intracerebral haemorrhage: study protocol for a randomised controlled trial
  144. Antiplatelet therapy with aspirin, clopidogrel, and dipyridamole versus clopidogrel alone or aspirin and dipyridamole in patients with acute cerebral ischaemia (TARDIS): a randomised, open-label, phase 3 superiority trial
  145. The use of text-mining and machine learning algorithms in systematic reviews: reducing workload in preclinical biomedical sciences and reducing human screening error
  146. A systematic review and meta-analysis of topoisomerase inhibition in pre-clinical glioma models
  147. Estimating the statistical performance of different approaches to meta-analysis of data from animal studies in identifying the impact of aspects of study design
  148. Facilitating healthcare decisions by assessing the certainty in the evidence from preclinical animal studies
  149. Learning lessons from MVA85A, a failed booster vaccine for BCG
  150. Transparency in the reporting of in vivo pre-clinical pain research: The relevance and implications of the ARRIVE (Animal Research: Reporting In Vivo Experiments) guidelines
  151. Correction: D-galactose-induced brain ageing model: A systematic review and meta-analysis on cognitive outcomes and oxidative stress indices
  152. Statistical analysis plan for the EuroHYP-1 trial: European multicentre, randomised, phase III clinical trial of the therapeutic hypothermia plus best medical treatment versus best medical treatment alone for acute ischaemic stroke
  153. Identification and characterization of outcome measures reported in animal models of epilepsy: Protocol for a systematic review of the literature-A TASK2 report of the AES/ILAE Translational Task Force of the ILAE
  154. Living systematic reviews: 2. Combining human and machine effort
  155. Living systematic reviews: 3. Statistical methods for updating meta-analyses
  156. Living systematic reviews: 4. Living guideline recommendations
  157. Risk of bias reporting in the recent animal focal cerebral ischaemia literature
  158. Marine-derived n-3 fatty acids therapy for stroke
  159. The Experimental Design Assistant
  160. The Experimental Design Assistant
  161. Findings of a retrospective, controlled cohort study of the impact of a change in Nature journals' editorial policy for life sciences research on the completeness of reporting study design and execution
  162. Standardized mean differences cause funnel plot distortion in publication bias assessments
  163. Living systematic review: 1. Introduction—the why, what, when, and how
  164. D-galactose-induced brain ageing model: A systematic review and meta-analysis on cognitive outcomes and oxidative stress indices
  165. Development of a psychological intervention for fatigue after stroke
  166. The IMPROVE Guidelines (Ischaemia Models: Procedural Refinements Of in Vivo Experiments)
  167. Alpha Calcitonin Gene-Related Peptide Increases Cerebral Vessel Diameter in Animal Models of Subarachnoid Hemorrhage: A Systematic Review and Meta-analysis
  168. Increasing value and reducing waste in stroke research
  169. Conjugal amyotrophic lateral sclerosis: a case report from Scotland
  170. Effect size and statistical power in the rodent fear conditioning literature - a systematic review
  171. Evolution of ischemic damage and behavioural deficit over 6 months after MCAo in the rat: Selecting the optimal outcomes and statistical power for multi-centre preclinical trials
  172. No publication without confirmation
  173. Hypothermia revisited: Impact of ischaemic duration and between experiment variability
  174. Improving our understanding of thein vivomodelling of psychotic disorders: A protocol for a systematic review and meta‐analysis
  175. Protocol for a systematic review and meta-analysis of experimental models of amyotrophic lateral sclerosis
  176. Understanding in vivo modelling of depression in non-human animals: a systematic review protocol
  177. Protocols for laboratory research
  178. Evaluating mesenchymal stem cell therapy for sepsis with preclinical meta-analyses prior to initiating a first-in-human trial
  179. The Devil Is in the Details: Incomplete Reporting in Preclinical Animal Research
  180. Study protocol - A systematic review and meta-analysis of hypothermia in experimental traumatic brain injury: Why have promising animal studies not been replicated in pragmatic clinical trials?
  181. Multicenter Evaluation of Geometric Accuracy of MRI Protocols Used in Experimental Stroke
  182. Systematic Review and Meta-Analysis of the Efficacy of Interleukin-1 Receptor Antagonist in Animal Models of Stroke: an Update
  183. Protocol for a systematic review of effect sizes and statistical power in the rodent fear conditioning literature
  184. The Efficacy of Trastuzumab in Animal Models of Breast Cancer: A Systematic Review and Meta-Analysis
  185. From a mouse: systematic analysis reveals limitations of experiments testing interventions in Alzheimer's disease mouse models
  186. A proposed framework for the systematic review and integrated assessment (SYRINA) of endocrine disrupting chemicals
  187. Failed trials for central nervous system disorders do not necessarily invalidate preclinical models and drug targets
  188. Olfactory Ensheathing Cell Transplantation in Experimental Spinal Cord Injury: Effect size and Reporting Bias of 62 Experimental Treatments: A Systematic Review and Meta-Analysis
  189. SWIFT-Review: a text-mining workbench for systematic review
  190. Protocol for a retrospective, controlled cohort study of the impact of a change in Nature journals’ editorial policy for life sciences research on the completeness of reporting study design and execution
  191. Cause of Death and Predictors of All‐Cause Mortality in Anticoagulated Patients With Nonvalvular Atrial Fibrillation: Data From ROCKET AF
  192. Cardiac Stem Cell Treatment in Myocardial InfarctionNovelty and Significance
  193. Corrigendum to ‘Meta-analysis of data from animal studies: A practical guide’
  194. How to Avoid Bumping into the Translational Roadblock
  195. AVERT 2 (a very early rehabilitation trial, a very effective reproductive trigger): retrospective observational analysis of the number of babies born to trial staff
  196. Effect of alteplase on the CT hyperdense artery sign and outcome after ischemic stroke
  197. Correction: Risk of Bias in Reports of In Vivo Research: A Focus for Improvement
  198. Informatics: Make sense of health data
  199. How individual participant data meta-analyses have influenced trial design, conduct, and analysis
  200. Translational failure of anti-inflammatory compounds for myocardial infarction: a meta-analysis of large animal models
  201. Risk of Bias in Reports of In Vivo Research: A Focus for Improvement
  202. The Clots in Legs Or sTockings after Stroke (CLOTS) 3 trial: a randomised controlled trial to determine whether or not intermittent pneumatic compression reduces the risk of post-stroke deep vein thrombosis and to estimate its cost-effectiveness
  203. Consent for Brain Tissue Donation after Intracerebral Haemorrhage: A Community-Based Study
  204. Exploring threats to generalisability in a large international rehabilitation trial (AVERT)
  205. Interventions for post-stroke fatigue
  206. Efficacy and safety of very early mobilisation within 24 h of stroke onset (AVERT): a randomised controlled trial
  207. Effect of Endothelin Receptor Antagonists on Clinically Relevant Outcomes after Experimental Subarachnoid Hemorrhage: A Systematic Review and Meta-Analysis
  208. Prof Benchie and Dr Athena-A modern tragedy…
  209. Increasing value and reducing waste in animal models of rheumatological disease
  210. Drug Repurposing: A Systematic Approach to Evaluate Candidate Oral Neuroprotective Interventions for Secondary Progressive Multiple Sclerosis
  211. Antiplatelet treatment compared with anticoagulation treatment for cervical artery dissection (CADISS): a randomised trial
  212. Experimental design and reporting standards for improving the internal validity of pre-clinical studies in the field of pain: Consensus of the IMI-Europain consortium
  213. Uptake of systematic reviews and meta-analyses based on individual participant data in clinical practice guidelines: descriptive study
  214. Magnetic Resonance Imaging in Experimental Stroke and Comparison With Histology
  215. Model of Understanding Fatigue After Stroke
  216. Influence of Intracerebral Hemorrhage Location on Incidence, Characteristics, and Outcome
  217. A systematic review and meta‐analysis of gene therapy in animal models of cerebral glioma: why did promise not translate to human therapy?
  218. Incidence, prevalence, and predictors of chemotherapy-induced peripheral neuropathy: A systematic review and meta-analysis
  219. Effect of intermittent pneumatic compression on disability, living circumstances, quality of life, and hospital costs after stroke: secondary analyses from CLOTS 3, a randomised trial
  220. Similar Effect of Autologous and Allogeneic Cell Therapy for Ischemic Heart Disease: Systematic Review and Meta-Analysis of Large Animal Studies
  221. Efficacy of Antidepressants in Animal Models of Ischemic Stroke: A Systematic Review and Meta-Analysis
  222. Preclinical research: Design animal studies better
  223. Efficacy and Safety of Rivaroxaban Compared With Warfarin Among Elderly Patients With Nonvalvular Atrial Fibrillation in the Rivaroxaban Once Daily, Oral, Direct Factor Xa Inhibition Compared With Vitamin K Antagonism for Prevention of Stroke and Embol...
  224. EuroHYP-1: European Multicenter, Randomized, Phase III Clinical Trial of Therapeutic Hypothermia plus Best Medical Treatment vs. Best Medical Treatment Alone for Acute Ischemic Stroke
  225. End-of-life decisions in patients with severe acute brain injury
  226. Psychological Associations of Poststroke Fatigue: A Systematic Review and Meta-Analysis
  227. Using Animal Models to Understand Cancer Pain in Humans
  228. Outcome After Conservative Management or Intervention for Unruptured Brain Arteriovenous Malformations
  229. Clopidogrel Plus Aspirin Versus Warfarin in Patients With Stroke and Aortic Arch Plaques
  230. Research: increasing value, reducing waste – Authors' reply
  231. Systematic Reviews and Meta-Analysis of Preclinical Studies: Why Perform Them and How to Appraise Them Critically
  232. Exercise Reduces Infarct Volume and Facilitates Neurobehavioral Recovery
  233. Therapeutic Hypothermia and the Risk of Infection
  234. A (mini) pill for stroke?
  235. Some Salt with Your Statin, Professor?
  236. Hypothermia Protects Human Neurons
  237. Systematic Review and Meta-Analysis of Interventions Tested in Animal Models of Lacunar Stroke
  238. Meta-analysis of data from animal studies: A practical guide
  239. Increasing value and reducing waste in research design, conduct, and analysis
  240. Increasing value and reducing waste in biomedical research regulation and management
  241. Effect and Reporting Bias of RhoA/ROCK-Blockade Intervention on Locomotor Recovery After Spinal Cord Injury
  242. Biomedical research: increasing value, reducing waste
  243. Efficacy and safety of mesenchymal stromal cells in preclinical models of acute lung injury: a systematic review protocol
  244. Stem Cell Transplantation in Traumatic Spinal Cord Injury: A Systematic Review and Meta-Analysis of Animal Studies
  245. Edoxaban versus Warfarin in Patients with Atrial Fibrillation
  246. Bringing rigour to translational medicine
  247. Edaravone Improves Functional and Structural Outcomes in Animal Models of Focal Cerebral Ischemia: A Systematic Review
  248. Meta-Analysis of Pre-Clinical Studies of Early Decompression in Acute Spinal Cord Injury: A Battle of Time and Pressure
  249. Systematic Review and Meta-Analysis of Therapeutic Hypothermia in Animal Models of Spinal Cord Injury
  250. Effectiveness of intermittent pneumatic compression in reduction of risk of deep vein thrombosis in patients who have had a stroke (CLOTS 3): a multicentre randomised controlled trial
  251. Evaluation of Excess Significance Bias in Animal Studies of Neurological Diseases
  252. Hypertension and Experimental Stroke Therapies
  253. Animal models of bone cancer pain: Systematic review and meta-analyses
  254. Systematic review and stratified meta-analysis of the efficacy of RhoA and Rho kinase inhibitors in animal models of ischaemic stroke
  255. Prevalence and natural history of pain in adults with multiple sclerosis: Systematic review and meta-analysis
  256. A Concerted Appeal for International Cooperation in Preclinical Stroke Research
  257. Evidence-based Translational Medicine
  258. Systematic review and meta-analysis of temozolomide in animal models of glioma: was clinical efficacy predicted?
  259. Role of multidetector computed tomography in the diagnosis and management of patients attending the rapid access chest pain clinic, The Scottish computed tomography of the heart (SCOT-HEART) trial: study protocol for randomized controlled trial
  260. A call for transparent reporting to optimize the predictive value of preclinical research
  261. Vorapaxar for secondary prevention of thrombotic events for patients with previous myocardial infarction: a prespecified subgroup analysis of the TRA 2°P-TIMI 50 trial
  262. The Benefit of Hypothermia in Experimental Ischemic Stroke is Not Affected by Pethidine
  263. Improving the Efficiency of the Development of Drugs for Stroke
  264. Translational Research
  265. Stem Cell-Based Therapy for Experimental Stroke: A Systematic Review and Meta-Analysis
  266. Voltage-gated potassium channel antibody-related encephalopathy: a case which may extend the documented phenotype of this condition
  267. The benefits and harms of intravenous thrombolysis with recombinant tissue plasminogen activator within 6 h of acute ischaemic stroke (the third international stroke trial [IST-3]): a randomised controlled trial
  268. Antiplatelet therapy and the effects of B vitamins in patients with previous stroke or transient ischaemic attack: a post-hoc subanalysis of VITATOPS, a randomised, placebo-controlled trial
  269. Pharmacologic Reduction of Angiographic Vasospasm in Experimental Subarachnoid Hemorrhage: Systematic Review and Meta-Analysis
  270. Vorapaxar in the Secondary Prevention of Atherothrombotic Events
  271. Rivaroxaban compared with warfarin in patients with atrial fibrillation and previous stroke or transient ischaemic attack: a subgroup analysis of ROCKET AF
  272. Untreated clinical course of cerebral cavernous malformations: a prospective, population-based cohort study
  273. Evaluation of Combination Therapy in Animal Models of Cerebral Ischemia
  274. Update on the third international stroke trial (IST-3) of thrombolysis for acute ischaemic stroke and baseline features of the 3035 patients recruited
  275. The timing, extent, progression and regression of deep vein thrombosis in immobile stroke patients: observational data from the CLOTS multicenter randomized trials
  276. Preclinical studies of human disease: Time to take methodological quality seriously
  277. Why animal research needs to improve
  278. Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation
  279. Sodium and chloride channelopathies with myositis: Coincidence or connection?
  280. Terutroban versus aspirin in patients with cerebral ischaemic events (PERFORM): a randomised, double-blind, parallel-group trial
  281. Dopamine agonists in animal models of Parkinson’s disease: A systematic review and meta-analysis
  282. Not Tonight, Darling, I Might Get a Headache
  283. Systematic Survey of the Design, Statistical Analysis, and Reporting of Studies Published in the 2008 Volume of the Journal of Cerebral Blood Flow and Metabolism
  284. Treatment of intracerebral hemorrhage in animal models: Meta-analysis
  285. Systematic Survey of the Design, Statistical Analysis, and Reporting of Studies Published in the 2008 Volume of theJournal of Cerebral Blood Flow and Metabolism
  286. Animal models of neurological disease: are there any babies in the bathwater?
  287. Hypothermia for Stroke: Call to Action 2010
  288. Preclinical Drug Evaluation for Combination Therapy in Acute Stroke Using Systematic Review, Meta-Analysis, and Subsequent Experimental Testing
  289. B vitamins in patients with recent transient ischaemic attack or stroke in the VITAmins TO Prevent Stroke (VITATOPS) trial: a randomised, double-blind, parallel, placebo-controlled trial
  290. Improving the translational hit of experimental treatments in multiple sclerosis
  291. Factors Affecting the Apparent Efficacy and Safety of Tissue Plasminogen Activator in Thrombotic Occlusion Models of Stroke: Systematic Review and Meta-Analysis
  292. Different Strokes for Different Folks: The Rich Diversity of Animal Models of Focal Cerebral Ischemia
  293. Comment on "Detection of an Infectious Retrovirus, XMRV, in Blood Cells of Patients with Chronic Fatigue Syndrome"
  294. Therapeutic Hypothermia for Acute Ischemic Stroke: Ready to Start Large Randomized Trials?
  295. Publication Bias in Reports of Animal Stroke Studies Leads to Major Overstatement of Efficacy
  296. Can Animal Models of Disease Reliably Inform Human Studies?
  297. How to Avoid Bumping into the Translational Roadblock
  298. A Systematic Review and Meta-Analysis of Erythropoietin in Experimental Stroke
  299. Emulating Multicentre Clinical Stroke Trials: A New Paradigm for Studying Novel Interventions in Experimental Models of Stroke
  300. Bacterial meningitis associated with a complex ischiorectal abscess
  301. Stroke research at a road block: the streets from adversity should be paved with meta-analysis and good laboratory practice
  302. Systematic Review and Stratified Meta-analysis of the Efficacy of Interleukin-1 Receptor Antagonist in Animal Models of Stroke
  303. Scope of Preclinical Testing Versus Quality Control Within Experiments
  304. Injury-induced mineralocorticoid receptor expression involves differential promoter usage: A novel role for the rat MRβ variant
  305. Effectiveness of thigh-length graduated compression stockings to reduce the risk of deep vein thrombosis after stroke (CLOTS trial 1): a multicentre, randomised controlled trial
  306. Reprint: Good Laboratory Practice: Preventing Introduction of Bias at the Bench
  307. Stroke Therapy Academic Industry Roundtable (STAIR) Recommendations for Extended Window Acute Stroke Therapy Trials
  308. Surgical decompression for space-occupying cerebral infarction (the Hemicraniectomy After Middle Cerebral Artery infarction with Life-threatening Edema Trial [HAMLET]): a multicentre, open, randomised trial
  309. Mineralocorticoid receptor mRNA expression is increased in human hippocampus following brief cerebral ischaemia
  310. Update of the Stroke Therapy Academic Industry Roundtable Preclinical Recommendations
  311. REPRINT: Good Laboratory Practice: Preventing Introduction of Bias at the Bench
  312. Effect of hyperthermia and anoxia on glucocorticoid and mineralocorticoid receptor expression in neonatal rat hippocampus
  313. Rationale and Design of a Randomized, Double-Blind, Parallel-Group Study of Terutroban 30 mg/day versus Aspirin 100 mg/day in Stroke Patients: The Prevention of Cerebrovascular and Cardiovascular Events of Ischemic Origin with Terutroban in Patients wi...
  314. General anaesthesia versus local anaesthesia for carotid surgery (GALA): a multicentre, randomised controlled trial
  315. The Future of Restorative Neurosciences in Stroke: Driving the Translational Research Pipeline From Basic Science to Rehabilitation of People After Stroke
  316. What is the translational efficacy of chemotherapeutic drug research in neuro-oncology? A systematic review and meta-analysis of the efficacy of BCNU and CCNU in animal models of glioma
  317. Reprint: Good Laboratory Practice: Preventing Introduction of Bias at the Bench
  318. Secondary prevention of stroke – Authors' reply
  319. Good Laboratory Practice: Preventing Introduction of Bias at the Bench
  320. Evidence for the Efficacy of NXY-059 in Experimental Focal Cerebral Ischaemia Is Confounded by Study Quality
  321. Stroke
  322. Predicting outcome in hyper-acute stroke: validation of a prognostic model in the Third International Stroke Trial (IST3)
  323. Outcome after interventional or conservative management of unruptured brain arteriovenous malformations: a prospective, population-based cohort study
  324. Empirical Evidence of Bias in the Design of Experimental Stroke Studies: A Metaepidemiologic Approach
  325. A Systematic Review and Meta-Analysis of the Efficacy of Piracetam and Piracetam-Like Compounds in Experimental Stroke
  326. How can we improve the pre-clinical development of drugs for stroke?
  327. Vanishing diplopia: a problem case
  328. Hypothermia in animal models of acute ischaemic stroke: a systematic review and meta-analysis
  329. Forebrain mineralocorticoid receptor overexpression enhances memory, reduces anxiety and attenuates neuronal loss in cerebral ischaemia
  330. Systematic Review and Meta-Analysis of the Efficacy of Tirilazad in Experimental Stroke
  331. Comparison of treatment effects between animal experiments and clinical trials: systematic review
  332. Hemicraniectomy after middle cerebral artery infarction with life-threatening Edema trial (HAMLET). Protocol for a randomised controlled trial of decompressive surgery in space-occupying hemispheric infarction
  333. Aortic Arch Atheroma
  334. 1,026 Experimental treatments in acute stroke
  335. Greater Incidence of Both Fatal and Nonfatal Strokes in Disadvantaged Areas: The Northeast Melbourne Stroke Incidence Study
  336. Current Issues in the Treatment of Acute Posterior Circulation Stroke
  337. Epilepsy update
  338. Surveying the literature from animal experiments: Systematic review and meta-analysis are important contributions
  339. Neuro-oncology for non-oncologists
  340. Overexpression of the mineralocorticoid receptor protects against injury in PC12 cells
  341. Systematic Review and Metaanalysis of the Efficacy of FK506 in Experimental Stroke
  342. Gender and deprivation and rates of referral and thereby admission to a national neurorehabilitation service
  343. Systematic review and meta-analysis of the efficacy of melatonin in experimental stroke
  344. Results of a Multicentre, Randomised Controlled Trial of Intra-Arterial Urokinase in the Treatment of Acute Posterior Circulation Ischaemic Stroke
  345. MicroRNA – Taking Regulation of Protein Synthesis to Another Level
  346. Nicotinamide Attenuates Focal Ischemic Brain Injury: Meta-Analysis or Mechanism of Protection
  347. Atheroma of the aortic arch: an important and poorly recognised factor in the aetiology of stroke
  348. Pooling of Animal Experimental Data Reveals Influence of Study Design and Publication Bias
  349. Media Watch
  350. Atheroma of the aortic arch: the missing link in the secondary prevention of stroke?
  351. Inequalities in the incidence and management of, and outcome from, neurological diseases in older people
  352. Mineralocorticoid receptor expression and increased survival following neuronal injury
  353. Effect of deprivation on time to hospital in acute stroke
  354. Reduced NMDA-induced apoptosis in neurons lacking ataxia telangiectasia mutated protein
  355. PubMed: http://www.pubmed.org
  356. Effect of deprivation and gender on the incidence and management of acute brain disorders
  357. What's a good doctor and how do you make one?
  358. Nitric-oxide-synthase-mediated cyclic guanosine monophosphate production in neonatal rat cerebellar prisms is resistant to calcineurin inhibition
  359. Serum withdrawal causes apoptosis in SHSY 5Y cells
  360. Caspase 6 activity initiates caspase 3 activation in cerebellar granule cell apoptosis
  361. The effect of tumour associated epilepsy on performance/handicap scales used in cerebral glioma
  362. Ischaemic heart disease and cholesterol There's more to heart disease than cholesterol